Terms: = Leukemia AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1
523 results:
1. Pro-Inflammatory Activation Suppresses TRAIL-induced Apoptosis of Acute Myeloid leukemia Cells.
Kobyakova MI; Senotov AS; Krasnov KS; Lomovskaya YV; Odinokova IV; Kolotova AA; Ermakov AM; Zvyagina AI; Fadeeva IS; Fetisova EI; Akatov VS; Fadeev RS
Biochemistry (Mosc); 2024 Mar; 89(3):431-440. PubMed ID: 38648763
[TBL] [Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. A Study on Geographic Correlation between Indoor Radon Exposure and leukemia Incidence in Canada.
Chen J
Health Phys; 2024 May; 126(5):315-321. PubMed ID: 38526250
[TBL] [Abstract] [Full Text] [Related]
4. Childbirth rates in women with myeloproliferative neoplasms.
Landtblom AR; Andersson TM; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Leukemia; 2024 May; 38(5):1081-1085. PubMed ID: 38461191
[TBL] [Abstract] [Full Text] [Related]
5. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia.
Jo T; Ueda T; Akahoshi Y; Kondo T; Uchida N; Tanaka M; Nakamae H; Doki N; Ota S; Sawa M; Ohigashi H; Maruyama Y; Takayama N; Nishida T; Hiramoto N; Katayama Y; Kanda Y; Ichinohe T; Atsuta Y; Arai Y;
Br J Haematol; 2024 May; 204(5):1913-1919. PubMed ID: 38420726
[TBL] [Abstract] [Full Text] [Related]
6. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic leukemia].
Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
[TBL] [Abstract] [Full Text] [Related]
7. Chronic Lymphocytic leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract] [Full Text] [Related]
8. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
9. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax.
Jain N; Croner LJ; Allan JN; Siddiqi T; Tedeschi A; Badoux XC; Eckert K; Cheung LWK; Mukherjee A; Dean JP; Szafer-Glusman E; Seymour JF
Clin Cancer Res; 2024 Feb; 30(3):498-505. PubMed ID: 37955424
[TBL] [Abstract] [Full Text] [Related]
10. In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation.
Brunner A; Thalhammer-Thurner GC; Willenbacher W; Haun M; Zelger BG; Willenbacher E
Ann Hematol; 2024 Feb; 103(2):553-563. PubMed ID: 37951851
[TBL] [Abstract] [Full Text] [Related]
11. Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis.
Kulíšková P; Vašátková L; Slaninová I
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895085
[TBL] [Abstract] [Full Text] [Related]
12. Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.
Zhang Y; Wu Q; Yuan B; Huang Y; Jiang L; Liu F; Yan P; Jiang Y; Ye J; Jiang X
BMC Cancer; 2023 Oct; 23(1):1030. PubMed ID: 37875840
[TBL] [Abstract] [Full Text] [Related]
13. Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL.
Liang EC; Albittar A; Huang JJ; Hirayama AV; Kimble EL; Portuguese AJ; Chapuis A; Shadman M; Till BG; Cassaday RD; Milano F; Kiem HP; Riddell SR; Turtle CJ; Maloney DG; Gauthier J
Blood Adv; 2023 Nov; 7(22):6990-7005. PubMed ID: 37774014
[TBL] [Abstract] [Full Text] [Related]
14. Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study.
Shao R; Zhang Y; He J; Huang F; Fan Z; Yang K; Xu Y; Xu N; Luo Y; Deng L; Zhang X; Chen J; Han M; Li X; Yu S; Liu H; Liang X; Luo X; Shi P; Wang Z; Jiang L; Zhou X; Lin R; Chen Y; Tu S; Sun J; Wang Y; Liu Q; Xuan L
Signal Transduct Target Ther; 2023 Sep; 8(1):348. PubMed ID: 37704613
[TBL] [Abstract] [Full Text] [Related]
15. Treatment Refractoriness in Chronic Lymphocytic leukemia: Old and New Molecular Biomarkers.
Maher N; Mouhssine S; Matti BF; Alwan AF; Gaidano G
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373521
[TBL] [Abstract] [Full Text] [Related]
16. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
Schrag D; Uno H; Rosovsky R; Rutherford C; Sanfilippo K; Villano JL; Drescher M; Jayaram N; Holmes C; Feldman L; Zattra O; Farrar-Muir H; Cronin C; Basch E; Weiss A; Connors JM;
JAMA; 2023 Jun; 329(22):1924-1933. PubMed ID: 37266947
[TBL] [Abstract] [Full Text] [Related]
17. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract] [Full Text] [Related]
18. A novel fluorescent nanoprobe for sensitive detection of 6-thioguanine in human serum based on Cu/Ag nanoclusters.
Chen W; Hu D; Yang M; Zhu Y; Wu Y; Li X; Zhang J; Yang J; Huang Y; Xie J
Anal Methods; 2023 May; 15(18):2270-2274. PubMed ID: 37129412
[TBL] [Abstract] [Full Text] [Related]
19. Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid leukemia by Targeting XPO1/eIF4E/c-MYC Signaling.
Long H; Hou Y; Li J; Song C; Ge Z
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047788
[TBL] [Abstract] [Full Text] [Related]
20. CD33 BiTE
Marcinek A; Brauchle B; Rohrbacher L; Hänel G; Philipp N; Märkl F; Strzalkowski T; Lacher SM; Udiljak D; Spiekermann K; Theurich S; Kobold S; Kischel R; James JR; Bücklein VL; Subklewe M
Cancer Immunol Immunother; 2023 Jul; 72(7):2499-2512. PubMed ID: 37041225
[TBL] [Abstract] [Full Text] [Related]
[Next]
